Integra LifeSciences Holdings (IART)

Fixed asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	1,596,615	1,533,335	1,521,985	1,473,066	1,486,381	1,488,778	1,493,656	1,509,844	1,505,291	1,519,581	1,519,648	1,510,233	1,535,982	1,529,270	1,504,267	1,371,086	1,317,264	1,323,744	1,339,441	1,466,719
Property, plant and equipment	US$ in thousands	405,723	390,906	373,570	345,356	340,199	318,718	317,571	315,175	311,302	300,729	302,423	309,209	311,703	293,921	295,759	296,193	287,529	294,439	334,334	335,903
Fixed asset turnover		3.94	3.92	4.07	4.27	4.37	4.67	4.70	4.79	4.84	5.05	5.02	4.88	4.93	5.20	5.09	4.63	4.58	4.50	4.01	4.37

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $1,596,615K ÷ $405,723K
= 3.94

The fixed asset turnover ratio for Integra LifeSciences Holdings has shown fluctuations over the past few years. The ratio increased from 4.37 on March 31, 2020, to a peak of 5.20 on September 30, 2021, indicating that the company was generating more revenue per dollar of fixed assets during that period.

Subsequently, the ratio experienced a slight decline, reaching 3.92 on September 30, 2024. This decline may suggest that the company's efficiency in utilizing its fixed assets to generate sales revenue decreased during this time frame.

Overall, the trend in Integra LifeSciences Holdings' fixed asset turnover ratio demonstrates variations in its ability to generate revenue from its fixed assets efficiently. Further analysis of the company's operational and investment strategies may be necessary to understand the factors contributing to these changes.